Fardous F. El-Senduny

Dr. Fardous F. El-Senduny

Chemistry Department, Faculty of Science, Mansoura University, Egypt
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
MFMohammad Hosein Farzaei
Mohammad Hosein Farzaei
MZMahdi Zobeiri
Mahdi Zobeiri
FPFatemeh Parvizi
Fatemeh Parvizi
Fardous F. El-SendunyFardous F. El-Senduny
Fardous F. El-Senduny
IMIlias Marmouzi
Ilias Marmouzi
MAMohammad Abdollahi
Mohammad Abdollahi
Oxidative stress has been considered a key causing factor of liver damage induced by a variety of agents, including alcohol, drugs, viral infections, environmental pollutants and dietary components, which in turn results in progression of liver injury, non-alcoholic steatohepatitis, non-alcoholic liver disease, liver fibrosis and cirrhosis. During the past 30 years and even after the major progress in the liver disease management, millions of people worldwide still suffer from an acute or chronic liver condition. Curcumin is one of the most commonly used indigenous molecules endowed by various shielding functionalities that protects the liver. The aim of the present study is to comprehensively review pharmacological effects and molecular mechanisms, as well as clinical evidence, of curcumin as a lead compound in the prevention and treatment of oxidative associated liver diseases. For this purpose, electronic databases including “Scopus,” “PubMed,” “Science Direct” and “Cochrane library” were extensively searched with the keywords “curcumin or curcuminoids” and “hepatoprotective or hepatotoxicity or liver” along with “oxidative or oxidant.” Results showed that curcumin exerts remarkable protective and therapeutic effects of oxidative associated liver diseases through various cellular and molecular mechanisms. Those mechanisms include suppressing the proinflammatory cytokines, lipid perodixation products, PI3K/Akt and hepatic stellate cells activation, as well as ameliorating cellular responses to oxidative stress such as the expression of Nrf2, SOD, CAT, GSH, GPx and GR. Taking together, curcumin itself acts as a free radical scavenger over the activity of different kinds of ROS via its phenolic, β-diketone and methoxy group. Further clinical studies are still needed in order to recognize the structure-activity relationships and molecular mechanisms of curcumin in oxidative associated liver diseases.

3 November 2019 in Biomolecules
Verified
Journal Article
Open access
PDF file
ZNZeinab Nouri
Zeinab Nouri
SFSajad Fakhri
Sajad Fakhri
Fardous F. El-SendunyFardous F. El-Senduny
Fardous F. El-Senduny
Nima SanadgolNima Sanadgol
Nima Sanadgol
GGGhada Emad Abdel Ghani
Ghada Emad Abdel Ghani
Jen-Tsung ChenJen-Tsung Chen
Jen-Tsung Chen
As a group of progressive, chronic, and disabling disorders, neurodegenerative diseases (NDs) affect millions of people worldwide, and are on the rise. NDs are known as the gradual loss of neurons; however, their pathophysiological mechanisms have not been precisely revealed. Due to the complex pathophysiological mechanisms behind the neurodegeneration, investigating effective and multi-target treatments has remained a clinical challenge. Besides, appropriate neuroprotective agents are still lacking, which raises the need for new therapeutic agents. In recent years, several reports have introduced naturally-derived compounds as promising alternative treatments for NDs. Among natural entities, flavonoids are multi-target alternatives affecting different pathogenesis mechanisms in neurodegeneration. Naringenin is a natural flavonoid possessing neuroprotective activities. Increasing evidence has attained special attention on the variety of therapeutic targets along with complex signaling pathways for naringenin, which suggest its possible therapeutic applications in several NDs. Here, in this review, the neuroprotective effects of naringenin, as well as its related pharmacological targets, signaling pathways, molecular mechanisms, and clinical perspective, are described. Moreover, the need to develop novel naringenin delivery systems is also discussed to solve its widespread pharmacokinetic limitation.

1 February 2019 in Bioorganic Chemistry
Verified
Journal Article
Closed access
MIMohammad Shahidul Islam
Mohammad Shahidul Islam
HGHussien Mansur Ghawas
Hussien Mansur Ghawas
Fardous F. El-SendunyFardous F. El-Senduny
Fardous F. El-Senduny
AAAbdullah Mohammed Al-Majid
Abdullah Mohammed Al-Majid
YEYaseen Elshaier
Yaseen Elshaier
Assem BarakatAssem Barakat
Assem Barakat

17 April 2018 in RSC Advances
Verified
Journal Article
Open access
PDF file
Assem BarakatAssem Barakat
Assem Barakat
MIMohammad Shahidul Islam
Mohammad Shahidul Islam
HGHussien Mansur Ghawas
Hussien Mansur Ghawas
AAAbdullah Mohammed Al-Majid
Abdullah Mohammed Al-Majid
Fardous F. El-SendunyFardous F. El-Senduny
Fardous F. El-Senduny
HGHazem A. Ghabbour
Hazem A. Ghabbour
Spirooxindole is a promising chemo therapeutic agent. Possible targets include cancers of the liver, prostate, lung, stomach, colon, and breast. Here, we demonstrate a one-pot three-component reaction via a [3 + 2] cycloaddition/ring contraction sequence of a dipolarophile (activated alkene) with in situ-generated azomethine ylide (1,3-dipoles) without the use of any catalyst. The reaction provides efficient access to synthetically useful and biologically important spirooxindoles in high yield (69–94%) with high diastereoselectivity. The synthesized compounds were subjected to cytotoxicity evaluation using colorectal cancer (HCT-116), hepatocellular carcinoma (HepG2), and prostate cancer (PC-3) cells. Compounds 4i, 4j, and 4k showed potent cytotoxic activity and high selectivity against HCT-116 cells when compared to cisplatin. Meanwhile compound 4d retained high cytotoxic activity and selectivity against HepG2 and PC-3 cells in comparison to cisplatin. The mechanism of compound 4d was further studied using phosphodiesterase 1 enzyme and showed 74.2% inhibitory activity. A possible binding mode for compound 4d to PDE-1 was investigated by molecular modeling using OpenEye software. Pose predictions for the active compounds were demonstrated by ROCS alignments. Compound 4d has a special geometry and differs from other active compounds.

1 May 2019 in Bioorganic Chemistry
Verified
Journal Article
Closed access
Assem BarakatAssem Barakat
Assem Barakat
MIMohammad Shahidul Islam
Mohammad Shahidul Islam
HGHussien Mansur Ghawas
Hussien Mansur Ghawas
AAAbdullah Mohammed Al-Majid
Abdullah Mohammed Al-Majid
Fardous F. El-SendunyFardous F. El-Senduny
Fardous F. El-Senduny
HGHazem A. Ghabbour
Hazem A. Ghabbour

5 August 2015 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
Fardous F. El-SendunyFardous F. El-Senduny
Fardous F. El-Senduny
FBFarid A. Badria
Farid A. Badria
AEAhmed M. El-Waseef
Ahmed M. El-Waseef
SCSubhash C. Chauhan
Subhash C. Chauhan
FHFathi Halaweish
Fathi Halaweish